Five of Kirin’s Proprietary Lactococcus lactis strain Plasma Products Registered as “Fo ods with Function Claims”

– First-ever Immune System Support Foods to Become Available in Japan – TOKYO–(BUSINESS WIRE)–Aug. 07, 2020 Kirin Holdings Company, Limited (TOKYO:2503) announced today that five of its products*1 that utilize Lactococcus lactis strain Plasma were registered as Foods with Function Claims with Japan’s Consumer Affairs Agency (CAA). This is the first time that an immune […]

LintonPharm Announces Authorization From China Health Authority to Proceed With a Global Phase 3 Trial Evaluating Catumaxomab in Advanced Gastric Cancer

GUANGZHOU, China–(BUSINESS WIRE)–Jul. 16, 2020 LintonPharm Co. Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T-cell engaging bispecific antibodies for cancer immunotherapy, today announced the China National Medical Products Administration (NMPA) authorized the company to proceed with a Phase III trial (clinicaltrials.gov: NCT04222114) for catumaxomab in patients with peritoneal carcinomatosis, a […]

Smiths Medical Acquires the Business of Access Scientific LLC Expanding Vascular Access Offering

MINNEAPOLIS–(BUSINESS WIRE)–May. 13, 2020 Smiths Medical, a leading global medical device manufacturer, announces today the acquisition of the business of Access Scientific, LLC, a privately-held company based in San Diego, CA. Access Scientific is a broad-spectrum vascular access and infection prevention company that manufactures the POWERWAND™ midline and extended dwell catheters. The range of POWERWAND™ […]

Supreme Court Rules in Favor of Hisky; Echosens (Shanghai) to Compensate Hisky for Its Illegal Acts Including Fabricating Information and Constituting Business Defaming

BEIJING–(BUSINESS WIRE)–May. 13, 2020 Recently, Shanghai Echosens Medical Equipment Technology Co., Ltd. (hereinafter referred to as “Echosens (Shanghai)”) and Fu-Rui Corporation, parent company of Echosens SAS, (hereinafter referred to as “Fu-Rui”), were determined by the Supreme People’s Court of China to have fabricated information to constitute business defaming against their opponent Wuxi HISKY Medical Technologies Co., Ltd. […]

Topcon Singapore Medical Announces its New Managing Director

Leo Hiroshi Nagatake leads the company from 1st April 2020. SINGAPORE–(BUSINESS WIRE)–Apr. 23, 2020 Topcon Singapore Medical Pte. Ltd. (“TSM”) has announced that Leo Hiroshi Nagatake, who is currently leading Topcon Healthcare Solutions Asia Pacific (”THSAP”), has been appointed as TSM’s new managing director. Leo has succeeded Calvin Lee, the former managing director of TSM, […]

Largest Statistically Significant Study by 6 200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context

Sermo Reports on Hydroxychloroquine Efficacy, Rise in Prophylaxis Use; Over 80% Expect 2nd Outbreak NEW YORK–(BUSINESS WIRE)–Apr. 02, 2020 Widespread confusion, conflicting reports, inconsistent testing, and off-indication use of existing and experimental drugs has resulted in no single source of information from the frontlines. To create a centralized and dynamic knowledge base, Sermo, the largest […]

Aptorum Group Collaborates with Covar Pharmaceuticals To Investigate at Least 3 Repurposed Drug Candida tes (SACT-COV19) for Coronavirus Disease 2019 (COVID-19) under Existing Smart-ACT™ Platform and Acticule Infectious Di sease Platform

NEW YORK–(BUSINESS WIRE)–Mar. 30, 2020 Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs including but not limited to infectious, orphan and metabolic disease areas, today announced that it is initiating an additional research and development project targeting the coronavirus group and has completed […]

New Treatment for Parkinson’s Disease Developed at NTHU

HSINCHU, Taiwan–(BUSINESS WIRE)–Mar. 12, 2020 Ultrasound is widely used for conducting physical examinations, and plans are underway for expanding its application to the treatment of Parkinson's disease, dementia, and diabetes. A research team at National Tsing Hua University led by Associate Professor Yu-Chun Lin of the Institute of Molecular Medicine and Professor Chih-kuang Yeh of […]

Takeda Completes Sale of Select OTC and Non-Core Assets to Acino

OSAKA, Japan–(BUSINESS WIRE)–Mar. 02, 2020 Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of Near East, Middle East and Africa countries within its Growth and Emerging Markets Business Unit (GEM BU) to Acino for a […]

Takeda Agrees to Divest Select OTC and Non-Core Assets in Latin America to Hypera Pharma for $825 Million USD

− Company further sharpens focus on patient access to innovative medicines in Latin America − Transaction further accelerates deleveraging OSAKA, Japan–(BUSINESS WIRE)–Mar. 02, 2020 Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core products exclusively in Latin America to Hypera S.A. (“Hypera Pharma”), Brazil’s […]

New Cancer Treatment Developed at NTHU

HSINCHU, Taiwan–(BUSINESS WIRE)–Feb. 27, 2020 A research team led by Dr. Yunching Chen and Tsai-Te Lu of National Tsing Hua University have recently developed a new treatment for cancer, in which blood vessels within malignant tumors are normalized by injecting a specially developed nanodelivery system for nitric oxide (NanoNO), which also facilitates the delivery of […]